Northville, Michigan -- Clean technology company Algal Scientific has landed $600,000 in new equity venture capital funding, according to an SEC regulatory filing.
Algal has developed what it calls Algamune, "an algae derived source of beta-1, 3-glucan for use in animals and humans."
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
Only one investor has participated in the offering to-date.
The company is still seeking $3.4 million in additional equity investment, according to the regulatory filing.